XML 61 R52.htm IDEA: XBRL DOCUMENT v3.23.1
Schedule of Percentage of Consolidated Revenues Attributable to Geographical Locations (Details) - Revenue Benchmark [Member] - Product Concentration Risk [Member]
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Disaggregation of Revenue [Line Items]    
Total 100.00% 100.00%
UNITED STATES    
Disaggregation of Revenue [Line Items]    
Total 17.00% 17.00%
Outside United States Pharma Services [Member]    
Disaggregation of Revenue [Line Items]    
Total 25.00% 9.00%
Outside United States Licensing [Member]    
Disaggregation of Revenue [Line Items]    
Total
Discontinued Operations Outside United States Licensing [Member]    
Disaggregation of Revenue [Line Items]    
Total
Discontinued Operations Determa Rx [Member]    
Disaggregation of Revenue [Line Items]    
Total 58.00% 74.00%